Lyra Therapeutics, Inc. - LYRA

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 20
Latest filed: Apr 03, 2026
Form Count
4 6
8-K 5
SCHEDULE 13D/A 4
144 3
SCHEDULE 13G 1
4/A 1

Latest files

Filed Form Report period Accession SEC
Apr 03, 2026 4 Apr 01, 2026 0001193125-26-142099 View
Apr 03, 2026 4 Apr 01, 2026 0001193125-26-142100 View
Mar 16, 2026 8-K Mar 13, 2026 0001193125-26-108439 View
Feb 27, 2026 8-K Feb 23, 2026 0001193125-26-083251 View
Feb 06, 2026 8-K Feb 02, 2026 0001193125-26-041191 View
Jan 27, 2026 144 0001959173-26-000457 View
Jan 20, 2026 SCHEDULE 13G 0001535610-26-000011 View
Jan 12, 2026 8-K Jan 09, 2026 0001193125-26-009772 View
Jan 08, 2026 4 Jan 06, 2026 0001193125-26-007751 View
Jan 08, 2026 4 Jan 06, 2026 0001193125-26-007760 View
Jan 06, 2026 144 0001959173-26-000158 View
Nov 25, 2025 SCHEDULE 13D/A 0001193125-25-297287 View
Nov 18, 2025 SCHEDULE 13D/A 0001193125-25-286168 View
Nov 13, 2025 SCHEDULE 13D/A 0001193125-25-280470 View
Nov 13, 2025 4 Nov 11, 2025 0001193125-25-280481 View
Nov 12, 2025 8-K Nov 12, 2025 0001193125-25-277515 View
Nov 10, 2025 SCHEDULE 13D/A 0001193125-25-274535 View
Nov 10, 2025 4 Nov 06, 2025 0001193125-25-274540 View
Oct 14, 2025 144 0001959173-25-006439 View
Oct 08, 2025 4/A Oct 01, 2025 0001193125-25-234557 View